Roivant Sciences (ROIV) Competitor Comparison
We are evaluating the key criteria listed to compare Roivant Sciences (ROIV) against its competitors in the Biotechnology industry.
Market Capitalization
19 / 368Gross Profits
275 / 278Total Revenue
88 / 300EBITDA
335 / 337Free Cashflow
348 / 352Quick Ratio
172 / 357Earnings per Share
6 / 359Dividend yield
0 / 6Total Cash
15 / 358Performance 3 years
64 / 368Performance 5 years
117 / 368Performance 10 years
96 / 368Linearity 3 years
89 / 368Linearity 5 years
51 / 368Linearity 10 years
32 / 368Total Rank
252 / 368Dividend Rank
10 / 368Valuation Rank
328 / 368Piotroski Rank
138 / 368Muliplier Rank
197 / 368EBITDA - ROIV ranking 335 / 337
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.